Furthermore, other compounds like escin, zerumbone, oxymatrine and formononetin also demonstrated anti-tumor effects via the inhibition of the AKT/mTOR pathway in several preclinical models [186,187,188,189,190]. This evidence concerns the gene MTOR and neoplasm.